The use of antidepressant drugs in patients with heart disease

Journal of Clinical Psychiatry

Volumn 59, Issue SUPPL. 10, 1998, Pages 16-21

  Glassman, Alexander H ^a,c   Rodriguez, Ana I ^b   Shapiro, Peter A ^a  

^a Columbia University ^*  (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; FLECAINIDE; FLECAINIDE ACETATE; FLUOXETINE; IMIPRAMINE; NORTRIPTYLINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

CARDIOVASCULAR DISEASE; DEPRESSION; DRUG EFFICACY; DRUG SAFETY; HEART ARRHYTHMIA; HEART BLOCK; HEART DISEASE; HUMAN; ISCHEMIC HEART DISEASE; MORBIDITY; MORTALITY; ORTHOSTATIC HYPERTENSION; PRIORITY JOURNAL; REVIEW;

AGE FACTORS; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ARRHYTHMIA; COMORBIDITY; DEPRESSIVE DISORDER; HEART DISEASES; HUMANS; MYOCARDIAL ISCHEMIA; SEROTONIN UPTAKE INHIBITORS;

EID: 0031812944     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Glassman AH, Bigger JT Jr. Cardiovascular effects of therapeutic doses of tricyclic antidepressants: a review. Arch Gen Psychiatry 1981;38:815-820
2. Weeke A. Causes of death in manic-depressives. In: Schou M, Stromgren E, eds. Origin, Prevention and Treatment of Affective Disorders. London, England: Academic Press; 1979:289-299
3. Glassman AH, Shapiro PA. Depression and the course of coronary artery disease. Am J Psychiatry 1998;155:4-11
4. Murphy JM. Depression in the community: findings from the Stirling County Study. Can J Psychiatry 1990;35:390-396
5. Bruce ML, Leaf PJ, Rozal GPM, et al. Psychiatric status and 9-year mortality data in the New Haven Epidemiologic Catchment Area Study. Am J Psychiatry 1994;151:716-721
6. Frasure-Smith N, Lesperance F, Talajic M. Depression following myocardial infarction: impact on 6-month survival. JAMA 1993;270:1819-1825
7. Glassman AH, Roose SP, Giardina EGV, et al. Cardiovascular effects of tricyclic antidepressants. In: Meltzer HY, ed. Psychopharmacology: The Third Generation of Progress. New York, NY: Raven Press; 1987: 1437-1442
8. Glassman AH, Johnson LL, Giardina EGV, et al. The use of imipramine in depressed patients with congestive heart failure. JAMA 1983;250: 1997-2001
9. Bigger JT Jr, Giardina EGV, Perel JM, et al. Cardiac antiarrhythmic effect of imipramine hydrochloride. N Engl J Med 1977;296:206-208
10. Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989; 321:406-412
11. Glassman AH, Roose SP, Bigger JT Jr. The safety of tricyclic antidepressants in cardiac patients: risk/benefit reconsidered. JAMA 1993;269: 2673-2675
12. Roose SP, Glassman AH, Attia E, et al. Fluoxetine safety in patients with heart disease. Am J Psychiatry. In press
13. Roose SP, Laghrissi-Thode F, Kennedy JS, et al. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA 1998;279:287-291
14. Shapiro PA, Lidagoster L, Glassman AH. Depression and heart disease. Psychiatr Ann 1997;27:347-352
15. Ellison JM, Milofsky JE, Ely E. Fluoxetine-induced bradycardia and syncope in two patients. J Clin Psychiatry 1990;51:385-386
16. Roose SP, Dalack GW, Glassman AH, et al. Cardiovascular effects of bupropion in depressed patients with heart disease. Am J Psychiatry 1991; 148:512-516
17. Physicians' Desk Reference. 51st ed. Montvale, NJ: Medical Economics; 1997:1177-1180, 2825-2829
18. Skop BP, Brown TM. Potential vascular and bleeding complications of treatment with selective serotonin reuptake inhibitors. Psychosomatics 1996;37:12-16
19. Laghrissi-Thode F, Wagner WR, Pollock BG, et al. Elevated platelet factor 4 and beta-thromboglobulin plasma levels in depressed patients with ischemic heart disease. Biol Psychiatry 1997;42:290-295
20. Musselman DL, Tomer A, Manatunga AK, et al. Exaggerated platelet reactivity in major depression. Am J Psychiatry 1996;153:1313-1317
21. Pollock BG, Laghrissi-Thode F, Wagner WR, et al. Increased PF4 and Beta-TG in depressed patients with ischemic heart disease. Presented at the 34th annual meeting of the American College of Neuropsychopharmacology; December 11-14, 1995; San Juan, Puerto Rico; No. 121